The TE Air is reportedly the first handheld ultrasound device to offer dual connectivity to mobile devices or touch-based ultrasound systems.
Offering the promise of enhanced connectivity and dedicated presets for a variety of clinical exams, Mindray has launched TE Air, a wireless handheld ultrasound modality.
Mindray said the TE Air offers enhanced utility and accessibility, claiming that the device is the first handheld ultrasound that can be connected to mobile devices or the touch-based TE X Ultrasound System.
“The TE Air is a leap forward in ultrasound technology, offering comprehensive functionality inside or outside the hospital environment,” noted Wayne Quinn, the president of Mindray North America. “The new 2-in-1 innovative solution empowers clinicians to overcome the traditional constraints of cords and confined spaces, giving them access to premium scanning capability when and where they need it.”
The company noted a number of additional features with TE Air including:
• a phased array with exam presets for a variety of clinical exams including cardiac exams, transcranial imaging, lung imaging and OB/GYN exams;
• single crystal technology that facilitates high-resolution imaging quality; and
• a waterproof design that allows for easy cleaning of the device with compatible disinfectant products.
Possible Real-Time Adaptive Approach to Breast MRI Suggests ‘New Era’ of AI-Directed MRI
June 3rd 2025Assessing the simulated use of AI-generated suspicion scores for determining whether one should continue with full MRI or shift to an abbreviated MRI, the authors of a new study noted comparable sensitivity, specificity, and positive predictive value for biopsies between the MRI approaches.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Large Study Affirms Safety of Ultrasound Enhancing Agents for Echocardiography
May 16th 2025Those receiving ultrasound enhancing agents (UEAs) for transthoracic or stress echocardiography had lower odds of all-cause death in comparison to patients who did not have UEAs, according to a nationwide study involving 11.4 million patients.
BrightHeart Garners Third FDA Clearance for AI-Powered Assessments of Fetal Heart Ultrasound
May 14th 2025The latest FDA 510(k) clearance is for B-Right Views, an AI-enabled device, which provides automated detection of required views necessary for second- and third-trimester fetal heart ultrasound exams.